Introduction {#s1}
============

In recent years, non-communicable diseases (NCDs) have become an emerging cause of morbidity and mortality (\~ 12% global prevalence) ([@B42]). Neurological disorders constitute a significant proportion as the leading causes of death among all the other non-communicable diseases ([@B35]). The most common disorders of the nervous system are schizophrenia (\~ 40% prevalence in India) and epilepsy (\~ 45% prevalence in India), which are clinically presented by dysfunction of the interneurons, misbalancing neuronal homeostasis, ultimately leading to neurophysiological disintegration ([@B38]). It is estimated that by next decade, mental and behavioural disorders will lead to a reduction in the average life expectancy, nearly by one-fifth proportion ([@B52]). In India, an average of 65 people out of 1,000 inhabitants suffer from mental and behavioural disorders, wherein, maximum prevalence has been recorded for alcohol dependency afflicted mental disorders (\~ 6% prevalence), child and adolescent behavioural disorders (\~ 4.3% prevalence) and mood disorders (\~ 1.6% prevalence). These statistics makes it obvious that the prevalence of neurodegenerative disorders is escalating, however, effective and safe treatment modalities are still under infancy ([@B38]).

The chemotherapeutic moieties used currently for the treatment of neurological disorders face a daunting challenge of systemic delivery of the drugs to the central nervous system. Moreover, crossing the blood brain barrier after strenuous systemic administration is another challenge. Ultimately, the bioavailability of these drugs becomes low and therefore, lead to below- optimal efficacies ([@B97]). Several drug delivery vehicles and nano-formulations have been devised so as to facilitate the targeted delivery of the drug to the site of action, *i.e.*, the central nervous system, thereby bypassing the blood brain barrier ([@B80]; [@B97]). However, these strategies have also shown little success. Most of the neurodegenerative disorders are progressive in nature, and the cycle of etiological events usually have an early-onset which might get unnoticed or under-detected. In such a case, the therapies initiated after the onset of neuropathological asymptomatic etiologies will only have limited value for the patients ([@B89]). Moreover, the foresaid neuropathological conditions are manifested with several additional etiologies, wherein the chemotherapeutic modalities act typically on a single target, thereby providing only palliative care ([@B21]). Hence, natural compounds serve as the holistic option which act on multiple neural targets and are enriched with free radical scavenging polyphenolic compounds ([@B68]). These phytoconstituents have well-described antioxidant and anti-inflammatory properties which aids in protecting the neuronal cells against oxidative stress. Additionally, the natural compounds, such as flavonoids also aid in modulating the neuronal cell signalling pathways ([@B89]).

There are various herbs which are used in traditional medicine for the management of neurodegenerative diseases, for instance: *Centella asiatica* (L.) Urb., *Glycyrrhiza glabra* L., *Tinospora cordifolia* (Willd.) Hook. f. & Thomson, *Bacopa monnieri* (L.) Wettst. and *Nardostachys jatamansi* (D. Don) DC. ([@B50]). One such example is *Convolvulus prostratus* Forssk. (Syn. *Convolvulus pluricaulis* Choisy), which is commonly known as *Shankhpushpi* in *Ayurveda* and is widely recognized for its anxiolytic, antidepressant and nootropic activities ([@B50]). As per an ancient Indian medicinal scripture---*Charaka Samhita*---this plant is superior to other nootropic drugs (*Medhya rasayana*) of *Ayurveda*, however, a detailed ethnomedicinal update yet needs to be presented ([@B25]). The ensuing sections will provide an ethnomedicinal, phytochemical and pharmacological update of this cognitive booster herb, *C. prostratus* (CP).

Ethnomedicinal Update on *C. prostratus* {#s2}
========================================

*C. prostratus* belongs to Convolvulaceae family and is ubiquitous in the north-western regions of India ([@B63]). In *Ayurveda*, this herb is classically described as a memory and intellect booster. Moreover, it is employed in a variety of formulations used for the treatment of nervous disorders, such as insanity, epilepsy, hysteria, insomnia, and psycho-neurosis ([@B49]). Mechanistically, it reduces the spontaneous motor activity, thereby controlling the refluxes and frightening responses. It ultimately acts as a sedative moiety which initiates a persistent fall in blood pressure and cardiac contraction, thereby managing neurological pathologies, such as anxiety, insanity and epilepsy ([@B20]). The neuro-mechanistic aspects of this herb has been elucidated in [**Figure 1A**](#f1){ref-type="fig"}. Besides, this plant has manifold therapeutic utilities, wherein, a decoction of its shoots is used as a remedy for anaemia and weakness ([@B88]). More specifically, in ancient texts, this plant has been mentioned as *sara*, *medhya*, *vrsya* and *rasayana*, which refers to the laxative, nootropic, aphrodisiac and rejuvenator properties of this herb, respectively. Additionally, one of the revered ancient Indian medical practitioner, *Acharya Charaka* had used white-flowered variety of *C. prostratus* (*Shankhpushpi*) along with the juice of *Bacopa monnieri* (*Brahmi*), *Acorus calamus* (*Vacha*) and *Saussurea lappa* (*Kushtha*) for alleviating insanity and epilepsy. Similar views had been presented in *Chikitsasangraha* written by *Chakradatta*; *Kaideva Nighantu*; and *Ayurveda Saar Sangraha* ([@B49]).

![**(A)** Neuro-mechanistic aspects of *Convolvulus prostratus* (CP). Schematic representations of *C. prostratus* (CP) target and mode of action in neural system. CP reduces the lesions formed in the hippocampus (A); and amyloid plaque accumulation in hippocampus (A), cortex (P), basal ganglia (M) and cerebellum (E). CP also acts as GABA-A agonists and binds to lateral prefrontal cortex (O) and anterior cingulate cortex (N). CP deactivates the wake promoting areas, namely, tuberomamillary nucleus (J) located in the hypothalamus (K), locus coeruleus (I) and raphe nucleus (H). It also activates the sleep inducing areas of the brain, namely, preoptic nucleus (L). Moreover, CP activates the hypoactive regions situated in the prefrontal cortex (shaded pink area; O), and deactivates hyperactive regions situated in the anterior cingulate cortex (shaded green area; N). CP blocks the excessive production of dopamine as produced *via* substantia nigra (D). CP also removes the excessive calcification formed at the cranio-cervical junction (F). Additionally, CP removes the formation of thrombus in the carotid artery (G). **(B)** Main mechanisms and phytoconstituents responsible for neuro-pharmacological activities of *C. prostratus* (CP). This herb exhibits anti-convulsant, anti-depressant, anxiolytic, sedative, anti-inflammatory, anti-oxidant, analgesic, nootropic, spasmolytic and neuroprotective activities. Phyto-constituents belonging to diverse chemical families, namely, coumarins, alkaloids and polyphenols (see [**Table 2**](#T2){ref-type="table"}) are responsible for such evident neuro-pharmacological profile of the CP plant ([@B64]; [@B19]). Reported mechanisms of CNS action of CP phyto-constituents has been depicted in these schematics, with putative site of action has been marked with fluorescent green blobs.](fphar-11-00171-g001){#f1}

Besides *Ayurveda*, *C. prostratus* (CP) has also been used in *Siddha* system of medicine, wherein an oil obtained from this plant is used as a keratogenic agent for promoting hair growth ([@B34]). It is also believed that a paste prepared from its roots and flowers act as anti-aging agents, thereby indicating its apparent anti-oxidant activity ([@B1]). Furthermore, in *Unani* medicinal system, a syrup prepared with *C. prostratus* and *Piper nigrum* is prescribed in bleeding piles and venereal diseases ([@B49]). All the above mentioned ethnomedicinal uses of *C. prostratus* have been tabulated in [**Table 1**](#T1){ref-type="table"}.

###### 

Ethnomedicinal uses of *Convolvulus prostratus* (CP) with predominant plant parts and mode of herbal preparation.

  Disease Targeted            Part(s) used   Method of Preparation and Dosage (if any)
  --------------------------- -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Amnesia^†^                  Whole plant    Decoction of this herb used along with milk ([@B12]).
  Anorexia                    Leaf           Intact part used as such ([@B79]).
  Anxiety^†^                  Leaf, Flower   Intact parts used for treating anxiety neurosis ([@B58]).
  Arthritis                   Whole plant    Whole plant used for the management of arthritis, osteoarthritis and rheumatic pain ([@B66]).
  Asthma                      Leaf           Intact part used as such ([@B58]).
  Blood disorders             Whole plant    Whole plant is used ([@B63]).
  Bone fracture               Leaf, Flower   Paste of flowers and leaves used for the management of fracture ([@B87]).
  Bronchitis                  Leaf           Intact part used as such ([@B58]).
  Burning sensation^†^        Whole plant    Whole plant is used ([@B82]).
  Calculi                     Leaf           Intact part used as such ([@B58]).
  Constipation                Leaf, Stem     Intact parts used for the management of constipation ([@B55]).
  Cough                       Leaf           Intact part used as such ([@B79]).
  Dementia^†^                 Root, Flower   Paste of roots and flowers administered for the treatment of dementia ([@B1]).
  Diabetes                    Leaf           Paste of leaves (100 g) along with black pepper (3-4 grains) is to be administered once daily ([@B88]).
  Dyspnoea                    Leaf           Intact part used as such ([@B79]).
  Dysuria                     Whole plant    Jelly obtained from this plant (10 g) is mixed with honey (10 g) and is to be taken thrice a day ([@B14]).
  Edema                       Whole plant    Whole plant is used ([@B82]).
  Emesis                      Whole plant    Whole plant is used ([@B2]).
  Enuresis                    Whole plant    Powder of this plant along with *Hyoscyamus niger*, *Prunella vulgaris*, (l-2 g) and milk (100 mL) is to be taken along with twice a day ([@B14]).
  Epilepsy^†^                 Whole plant    Paste of this plant along with cumin seeds (l g) and milk thrice a day ([@B14]).
  Gonorrhoea                  Whole plant    Jelly obtained from this plant (10 g) is mixed with honey (10 g) and is to be taken thrice a day ([@B14]).
  Haemoptysis                 Leaf           Juice of the leaves has to be administered at a dose of 10 mL, thrice a day ([@B14]).
  Haemorrhoid                 Whole plant    Whole plant is used ([@B63]).
  Headache^†^                 Whole plant    Powder of plant (3 g) mixed with sugar (5 g) and milk (20 ml) is to be taken twice daily ([@B14]).
  Hematemesis                 Whole plant    Whole plant is used ([@B26]).
  Hysteria^†^                 Whole plant    Intact plant is used ([@B26]).
  Insomnia^†^                 Whole plant    Whole plant is used ([@B26]).
  Leprosy                     Whole plant    Whole plant is used ([@B63]).
  Leucoderma                  Whole plant    Whole plant is used ([@B14]).
  Menorrhagia                 Whole plant    Paste of this plant is taken along with milk ([@B37]).
  Neurological disorders^†^   Whole plant    Decoction of this herb is used along with cumin and milk for treating attention deficit hyperactivity disorder (ADHD), mild convulsions, depression, emotional stress, mental debility, memory loss, mental hypersensitivity, schizophrenia and stress disorders ([@B58]; [@B93]).
  Polydipsia                  Leaf, Stem     Intact parts used for the management of excessive thirst ([@B55]).
  Pyrexia                     Root, Leaf     Intact parts used for alleviating fever ([@B12]).
  Pyrosis                     Leaf, Stem     Intact parts used for the management of heart burn or pyrosis ([@B55]).
  Scrofula                    Whole plant    Decoction of this herb is used along with cumin and milk ([@B58]).
  Sexual debility             Whole plant    This plant (100 g) is ground with little water and taken with sugar or honey once daily, for 21 days ([@B14]).
  Snake bite                  Whole plant    Whole plant is used ([@B82]).
  Stomachache                 Whole plant    One tea spoon powder of dried plant is taken for the management of stomachache ([@B47]).
  Syphilis                    Whole plant    Decoction of this herb is used along with cumin and milk ([@B58]).
  Ulcer                       Root           Intact part used as such ([@B14]).
  Urinary diseases            Leaf           Intact part used as such ([@B79]).
  Vertigo^†^                  Whole plant    A syrup prepared from this herb is used for the management of vertigo ([@B34]).
  Worm infestation            Whole plant    Whole plant is used ([@B37]).
  Wound                       Whole plant    Whole plant is used ([@B98]).

^†^Shaded rows indicate specific neurological diseases which can be managed by the administration of C. prostratus.

Industrial Significance of *C. prostratus* {#s3}
==========================================

*C. prostratus* is extensively used in pharmaceutical, cosmeceutical and nutraceutical industries ([@B45]). In the pharmaceutical industry, various extracts, syrups and tablets are produced, specifically for targeting neurodegenerative diseases, hypertension, hypercholesterolemia and gastric ulcers. A few examples of such marketed herbal pharmaceutical formulations include Patanjali Divya Shankhpushpi Churna™, Divya Pharmacy Shankhpushpi Sharbat™, Baidyanath Shankhpushpi Sharbat™, Dabur Shankhpushpi Syrup™, Biotrex Shankhpushpi™, Maxmind capsule™, Herbal Hills Shankhpushpi Tablets™ and many more ([@B13]). Similarly, in the cosmeceutical industry, the CP herb is used as a general tonic for rejuvenating the skin and hairs, thereby treating skin related ailments as well as keratogenic disorders. A few examples for elucidating the use of CP (Shankhpushpi) as cosmeceutical ingredients include Econature Shankhpushpi Hair oil™, Khadi Natural Shankhpushpi oil™ and Alps Shankhpushpi hair Mask Powder™. Moreover, the CP powder and juice, such as, Jain Shankhpushpi Powder™ and Axiom Jeevan Ras Shankhpushpi Juice™, are also being used as skin mask for rejuvenating the skin and managing skin problems such as acne, blemishes and sun spots ([@B39]). Additionally, food grade CP powder and syrups are also available in the market for being used as a nutraceutical nootropic supplement, for example, Divya Pharmacy Shankhpushpi Sharbat™, Baidyanath Shankhpushpi Sharbat™, Shivalik Herbals Shankhpushpi Nutraceutical Capsules™ and Veg E Wagon *Shankhpushpi* Powder ([@B13]). Such extensive industrial uses of CP further confirms the holistic significance of this nontoxic wonder herb ([@B45]).

Phytomedicinal Formulations Containing *C. prostratus* {#s4}
======================================================

The CP herb has also been used as a phyto-ingredient of a polyherbal medicinal formulation: *Sankhahauli*, which contains leaves of *C. prostratus* (15 *g*); seeds of *Piper nigrum* (3 *g*) and *Papaver somniferum* (20 *g*); whole plant of *Prunus amygdalus* (10 g), *Vitis vinifera* (20 g) and *Coriandrum sativum* (10 *g*). This formulation is mainly used for the management of insomnia, drug addiction and hypertension ([@B14]). Several such marketed herbal formulations containing CP are being used for the management of a variety of neurological ailments in India, for example., *Divya Medha Vati*, *Divya Medha Kwath* (Patanjali Ayurved Ltd.); BR-16A (Himalaya Drug Co. Ltd.); *Dimagheen* (Dawakhana Tibiya College); *Shankhpushpi* syrup (Unjha); *Shankhavali Churna* (Narnaryan Pharmacy); Brain tab and *Shankhpushpi* syrup (Baidyanath Pharmaceuticals) ([@B4]; [@B84]; [@B6]).

Chemical Profile of *C. prostratus* {#s5}
===================================

All of these stated medicinal utilities of *C*. *prostratus* (CP) have been attributed to various phytoconstituents, belonging to the chemical family of alkaloids, flavonoids, coumarins and polyphenols. Among these phytoconstituents, certain compounds are known to be present at a higher concentration (almost 20% w/w) and are known as major phyto-constituents. CP plant is known to contain kaempferol, β-sitosterol, N-hexacosanol, taraxerol, taraxerone, delphinidine and hydroxy-cinnamic acid as the major phyto-constituents, as depicted in [**Table 2**](#T2){ref-type="table"} ([@B17]; [@B6]). Moreover, an alkaloid, namely, Sankhpuspine has also been isolated from this plant and is known as a chemotaxonomic marker for this species ([@B10]; [@B81]). CP plant also contains other alkaloids (convolamine, convosine, convoline, convolidine, convolvine, confoline, evolvine, phyllabine, subhirsine, sankhpuspine) ([@B2]; [@B8]); anthroquinones; carbohydrates (D-glucose, sucrose, rhamnose, maltose) ([@B26]; [@B13]; [@B2]); coumarins (ayapanin, scopolin, scopoletin); flavonoids (kaempferol, quercetin) ([@B51]); glycosides (geranilan-3-ol-1-carboxylate-1-O-β-D-xylopyranosyl-(2′→1′′)-O-β-D-xylopyranoside ([@B93]); phenolic compounds; steroids; tannins; and terpenoids ([@B75]; [@B2]; [@B8]; [@B56]).

###### 

Major phyto-constituents of *Convolvulus prostratus* (CP) with their reported medicinal utility.

  Name of the compound        Category of phytoconstituent   Chemical structure^†^          Medicinal profile
  --------------------------- ------------------------------ ------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Ayapanin**                Coumarin                       ![](fphar-11-00171-g002.jpg)   Improves scopolamine-induced spatial memory impairment ([@B105]); anti-nociceptive activity ([@B22]).
  **Convolamine**             Alkaloid                       ![](fphar-11-00171-g003.jpg)   Antihypoxic, immune-modulating, and anti-inflammatory activity ([@B33]).
  **Convoline**               Alkaloid                       ![](fphar-11-00171-g004.jpg)   Anti-epileptic activity ([@B28]).
  **Convolvine**              Alkaloid                       ![](fphar-11-00171-g005.jpg)   Antihypoxic, immune-modulating, and anti-inflammatory activity ([@B33]); blocks the M-receptors; exhibits nootropic, cytotoxic and sedative activity ([@B57]; [@B99]).
  **Delphinidine**            Anthocyanin                    ![](fphar-11-00171-g006.jpg)   Antioxidant, anti-mutagenic, anti-inflammatory and antiangiogenic ([@B69]).
  **Hydroxy-cinnamic acid**   Carboxylic acid                ![](fphar-11-00171-g007.jpg)   Antioxidant, photooxidant activity; strong inhibitory effect on the tumour U14 ([@B100]).
  **Kaempferol**              Flavonoid                      ![](fphar-11-00171-g008.jpg)   Activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndromes; potent inhibitory effect on *in vitro* bone resorption; anti-inflammatory, anti-oxidant activity; inhibition of cancer cell invasion through blocking the PKCδ/MAPK/AP-1 ([@B102]; [@B40]).
  **Quercetin**               Flavonoid                      ![](fphar-11-00171-g009.jpg)   Antioxidant activity; stimulator of recombinant SIRT1 and also a PI3K inhibitor; attenuated the function VEGFR, androgen receptor and the expressions of NF-κB, IL Receptor, FAK, ERK, Nrf2 ([@B104]).
  **Scopoletin**              Coumarin                       ![](fphar-11-00171-g010.jpg)   Antifungal, anti-allergic, anti-aging and hypouricemic activities ([@B94]; [@B61]).
  **Scopolin**                Coumarin glucoside             ![](fphar-11-00171-g011.jpg)   Antinociceptive activity; acetylcholinesterase (AChE) inhibitor; fungitoxic activity ([@B70]; [@B66]).
  **Taraxerol**               Triterpenoid                   ![](fphar-11-00171-g012.jpg)   Anti-inflammatory; anti-cancerous activity ([@B95]).
  **β-sitosterol**            Phytosterol                    ![](fphar-11-00171-g013.jpg)   Anti-inflammatory; anti-proliferation; anti-pyretic; pro-apoptotic activity ([@B36]; [@B67]).

^†^Source of Chemical structures: PubChem (<https://pubchem.ncbi.nlm.nih.gov/>).

Several other hydrocarbons, namely, 1- pentyl-2-tridecanyl cyclopentyl cyclohexane carboxylate, 1,2-benzenedicarboxylic acid, 10-bromodecanoic acid, 1-octadecanesulphonyl chloride, 2-butanone, 2-pentanol, 7- hydroxyheptadecanyl-1,7, 17-tricarboxylic acid, ascorbic acid, cyclononasiloxane, cyclo-octadecanyl methanol, decanoic acid, dicyclohexyl cyclo-octyl acetic acid, eicosane, heneicosane, hydroxy cinnamic acid, octatriacontyl pentafluoropropionate, pentadecyl 2-propyl ester, pentanoic acid, pentyl hexacosanoate, phthalic acid, silane, squalene, tetracyclohexanyl caproate and tridecane are also found in the extract of the CP plant ([@B12]; [@B56]; [@B72]; [@B93]).

In addition, CP is known to be a good source of vitamins and minerals, namely, calcium, copper, iron, magnesium, manganese, phosphorus, potassium, sulphur, zinc, vitamin C and E ([@B83]; [@B7]).

Neuro-Pharmacological Profile of *C. prostratus* {#s6}
================================================

Nootropic Activity {#s6_1}
------------------

*C. prostratus* (CP) contains volatile oil; fatty alcohols; flavonoids, *i.e.* kaempferol; hydroxy cinnamic acid; β-sitosterol; and carbohydrates such as glucose, rhamnose, sucrose *etc.*, which endow this plant with nootropic capabilities. Moreover, an alkaloid, namely, convolvine present in this herb has also been found to block cholinergic muscarinic receptors: M2 and M4. Convolvine also aids in potentiating the effect of another muscarinic memory enhancer, namely, arecoline, thereby imparting nootropic abilities to CP ([@B82]). In a study, Rawat and Kothiyal have also found that the aquo-methanolic, ethanolic and petroleum ether extracts isolated from CP (50--400 mg/Kg) exhibited anxiolytic, memory-enhancing and nootropic activity as evaluated by using Elevated Plus Maze (EPM) and step-down models in mice. EPM test has mainly been used to investigate the interactions between aversive memory and anxiety responses of the mice. CP effects on EPM activity has been found to be comparable to the standard of care drug, Piracetam ([@B76]; [@B48]). Moreover, treatment with alcoholic extract of CP plant led to an increase in the average time-span spent by mice in the enclosed arm of plus maze model, and an escalation in the mean avoidance response on the jumping box model ([@B76]).

Neuroprotective Activity {#s6_2}
------------------------

The aqueous extract of the roots of *C. prostratus* inhibited the activity of acetylcholinesterase (AChE) within the cortex and hippocampus of male Wistar rats, that have been intoxicated with scopolamine. CP extract also posed evident anti-oxidant activity and elevated the levels of glutathione reductase, superoxide dismutase and reduced glutathione within the cortex and hippocampus ([@B48]). Similar results have been observed in case of aluminium chloride induced neurotoxicity in rat cerebral cortex. Regular administration of the CP root extracts (150 mg/Kg) for 3 months inhibited the decline in Na^+^/K^+^ ATPase activity and also preserved the mRNA expression levels of muscarinic acetylcholine receptor 1 (M1 receptor), choline acetyl transferase (ChAT) and nerve growth factor-tyrosine kinase A receptor (NGF-TrkA) ([@B15]; [@B48]). The Na^+^/K^+^ ATPase pump aids in maintaining the osmotic equilibrium and membrane potential in neuronal cells ([@B31]). Secondly, the muscarinic receptors bind to the neurotransmitter acetylcholine, thereby facilitating the transmission of electrical signals within the central nervous system ([@B18]). Furthermore, the choline acetyl transferase enzyme is essential for the synthesis of neurotransmitter acetylcholine; and the nerve growth factor-tyrosine kinase A receptor is necessary for binding of the neuronal trophic factors, thereby ensuring the survival of the neurons ([@B46]; [@B41]).

In another experiments, it has been shown that the oral administration of the aqueous extract of the CP roots (150 mg/Kg) to scopolamine induced rats causes a marked reduction in the mRNA levels of tau protein ([@B16]). Such reduction in the tau protein expression is responsible for causing an amelioration in the amyloid β-induced deficits in case of neurodegenerative disorders such as Alzheimer\'s disease ([@B101]). Hence, the presence of phytoconstituents such as convolvine might be responsible for endowing CP with the abilities to regulate all the neuronal factors/proteins and enzymes, thereby showcasing its evident neuroprotective status ([@B82]; [@B77]).

Anxiolytic Activity {#s6_3}
-------------------

The ethanolic and chloroform extracts isolated from the aerial parts of CP showed significant anxiolytic activity as recorded using elevated plus maze test on experimental mice. There was increase in the time spent in open arms; and in the number of open arm entries upon the CP oral administration to mice at a dose of 200 mg/Kg ([@B12]). Similar results have also been observed in case of the ethanolic extract of the CP flower petals at doses 200--400 mg/Kg in mice ([@B48]).

In another study, CP methanolic extract was evaluated for anxiolytic activity on Obsessive Compulsive Disorders (OCDs) in mice by employing marble burying behaviour analysis, hole board and rota-rod tests. The results have shown that the mice group treated with 200--400 mg/Kg CP methanolic extracts can modulate serotonin or dopaminergic levels, thereby harmonizing the major pathway involving serotonergic or dopaminergic receptors manifesting obsessive compulsive disorders ([@B92]). Such anxiolytic activity can be linked with the hypotensive effect of this herb, which in turn is attributed to the presence of GABA-A-benzodiazepine agonists, such as convolamine and scopoletin ([**Figure 1B**](#f1){ref-type="fig"}) ([@B54]; [@B6]; [@B86]).

Anti-Convulsant Activity {#s6_4}
------------------------

The chloroform, ethanol and aqueous extracts of CP have been evaluated for anti-convulsant activity against strychnine induced as well as pentylene tetrazol (PTZ) induced convulsive seizures in different animal models. Five hundred mg/Kg concentration of the CP extracts have shown statistically significant (p \< 0.001) protection against strychnine and PTZ induced clonic convulsions ([@B73]; [@B86]). Methanolic extract of this plant (500--1000 mg/Kg) also exhibited anti-convulsant activity, as characterized by reduction in the mean recovery time of convulsions in case of maximal electroshock seizure model in mice ([@B48]).

The fundamental mechanism behind such evident anti-convulsing activity of CP might be the presence of coumarins and triterpenoids ([@B71]). Moreover, it has also been proposed that the anti-convulsant activity of a phyto-medicine is escalated by the presence of certain functional groups like, quinoline, quinazoline, thiazole, benzothiazines, oxadiazole, pyridine, pyrazole, imidazole, pyrimidine, phthalazine, triazine, triazoles, cyclopropane carboxylate, and oxime ether ([@B103]; [@B90]). Indeed, many such functional groups have been found in the CP phyto-constituents ([**Table 2**](#T2){ref-type="table"}) for *e.g.*, quinones, microphyllic acid, 6-methoxy coumarin, 4\'-methoxy kaempferol, 7-methoxy quercetin, vanillic acid, syringic acid and melilotic acid ([@B24]).

Anti-Depressant Activity {#s6_5}
------------------------

Bhalerao and co-workers have found that the chloroform fraction isolated from the CP ethanolic extract reversed the reserpine-induced extension of immobility period of mice in Forced Swim Test (FST), and elicited a significant antidepressant effect by interaction with adrenergic, dopaminergic and serotonergic systems ([@B12]). Similarly, a polyherbal formulation (Trans-01) containing *C. prostratus* (30%), *Valeriana wallichii* (45%), *Plumbago zeylanica* (7.5%), *Boswellia serrata* (15%) and *Acorus calamus* (3.5%) also exhibited similar anti-depressant properties as tested by employing the forced swim test (FST), tail suspension test (TST) and forced swimming stress (FSS)-induced alterations in serum corticosterone levels. In TST and FST, Trans-01 showed a dose-dependent decrease in immobility time. Moreover, Trans-01 significantly attenuated the elevated corticosteroid levels, thereby indicating a significant anti-depressant activity of this formulation ([@B85]). CP herb is known to contain alkaloids (convolamine and scopoletin), flavonoids (kaempferol), and steroids (phytosterol and β-sitosterol). These phytoconstituents most probably act as GABA-A-benzodiazepine agonists and bind to the GABA-A-benzodiazepine receptors, thereby causing an increase in the chloride ion flux and consequent hyperpolarization of the postsynaptic membrane. Such hyperpolarization leads to a hypnotic effect and may alleviate depression ([@B86]).

Anti-Inflammatory Activity {#s6_6}
--------------------------

Hydroxy-cinnamic acid is a phenyl-propanoid compound found in CP. It is known to cause a downregulation in the expression of cytokine mediators such as IL-8, MCP-1 and ICAM-1, thereby blocking the expression of cytokine-mediated adhesion molecules and therefore the fundamental process of leukocyte--endothelial cell adhesion is deterred ([@B17]; [@B74]). Hence, the CP herb may aid in ameliorating the conditions of neuro-inflammation and consequent cognitive impairment. Indeed, oral administration of the ethanolic extract of the CP leaves at dose of 800 mg/Kg, showed significant inhibition of rat paw edema, in the Carrageenan-induced paw edema and Cotton pellet-induced granuloma animal models ([@B3]).

Anti-Oxidant Activity {#s6_7}
---------------------

The reactive oxygen species are known to deteriorate the cellular physiology of nerve cells and ultimate lead to neurodegenerative disorders. Polyphenols, flavonoids and vitamin E present in the CP plant act as reactive oxygen species (ROS) scavengers and also ameliorate the lipid peroxidation, thereby attributing towards the anti-oxidant activity of CP ([@B62]). It has also been observed that the ethyl acetate and methanolic extract of CP have shown appreciable results (IC~50~ \~ 0.07 mg/mL and 0.075 mg/mL, respectively), as observed in 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Similarly, in Ferric Reducing Antioxidant Power (FRAP) analysis, aqueous CP extract has been found to be potentially active with anti-oxidant capacity of 460 ± 8 ascorbic acid equivalent/mg of the extract ([@B43]). Interestingly, the *Shankhpushpi* syrup and its isolated compounds (Scopoletin and Bacoside A) also exhibited evident anti-oxidant activity as evaluated by using DPPH assay with average IC~50~ value ranging from 0.94 - 2.39% v/v ([@B44]; [@B72]). Furthermore, the aqueous extract of CP roots diminished the endogenous levels of reactive oxygen species in tauopathy flies as induced by overexpression of τ-protein, thereby substantiating its oxidative stress ameliorative effect ([@B65]).

Analgesic and Spasmolytic Activity {#s6_8}
----------------------------------

The ethanolic extract of CP at dose 750 mg/Kg showed statistically significant analgesic activity as compared to the standard analgesics like, morphine sulphate, when tested in hot plate method and tail-flick assays in rats ([@B3]). Such evident analgesic activity is cohesively attributed by flavonoids, volatile oils, alkaloids, polyphenols and organic acids by means of prevention of the formation of cyclooxygenase enzyme and prostaglandins, *i.e.*, mediators of pain sensitization. Hence, these CP phyto-constituents ultimately aid in ameliorating the neuronal pain and headache ([@B5]).

The CP ethanolic extract has exhibited spasmolytic activity in isolated rabbit ileum, isolated rat uterus, intact intestine and tracheal muscles of dog ([@B9]). Such anti-spasmodic action is linked to the inhibition of acetylcholine production which is mainly brought about by the specific alkaloid present in this CP herb, convolvine ([@B6]).

Sedative Activity {#s6_9}
-----------------

Interestingly, the ethanolic and aqueous extracts of the CP aerial parts showed statistical significant potentiation of sleeping time in rats induced with thiopental sodium ([@B86]). In another similar experiment, the aqueous extract of the CP leaves and flowers showed an evident barbiturate hypnosis potentiation in albino rats at a dose of 300 mg/Kg ([@B59]). Such sedative activity is directly linked to the presence of phytoconstituents like convolamine and scopoletin which act similarly to GABA-A agonists, thereby bringing about the effects of sedation ([**Figure 1B**](#f1){ref-type="fig"}) ([@B86]).

This CP herb has also been reported for several other pharmacological activities, including anti-diabetic, anti-hyperlipidemic, anti-hypertensive, anti-microbial, anti-platelet aggregation, anti-ulcer, cardio-vascular, hepatoprotective, and hypothyroidism ([@B9]; [@B59]; [@B78]; [@B53]; [@B43]; [@B75]; [@B45]). Anti-diabetic activities of this plant might be attributed to the presence of tropane alkaloids which are known as potent inhibitor of α-glucosidases and R-galactosidases ([@B32]; [@B72]). The polyphenols present in this species act as reactive oxygen species (ROS) quenchers, thereby ameliorating the oxidative stress that is generated as a diabetic manifestation. Additionally, the presence of vitamin E in this herb also aids in controlling the levels of protein oxidation and lipid peroxidation, thereby leading to an escalation in the antioxidant defense system ([@B23]; [@B62]; [@B27]; [@B30]). Furthermore, the presence of GABA-A-benzodiazepine agonists, such as convolamine, scopoletin, ceryl alcohol, kaempferol, phytosterol, and β-sitosterol endow this herb with hypotensive and sedative activities ([@B54]; [@B86]). More specifically, a compound, namely, 29-oxodotriacontanol, isolated from the CP herb has also been assessed to possess antimicrobial and anti-fungal activity ([@B6]). Certain flavonoids and phenyl-propanoids from CP have been shown to provide anti-platelet aggregation and anti-ulcerogenic activity by means of inhibition of cyclic nucleotide phosphodiesterase enzyme and clot retraction capabilities ([@B11]; [@B96]). The anti-ulcerogenic effect was largely observed due to upregulation of mucosal defensive factors such as mucin and glycoprotein secretion, which in turn was induced by the flavonoids and steroids present in this herb ([@B91]). These flavonoids also pose the profound effects on the thyroid hormone regulation and deiodinase-1 inhibition, thereby endowing this herb with anti-thyroid activity ([@B60]). Additionally, the fundamental principle responsible for the cardio-vascular activity of this herb has been proposed to be linked with it alkaloid derivative, evolvine hydrochloride, which is known to exhibit lobeline-like action on the cardiovascular system. This phytoconstituent acts as a cardiac depressant, ultimately leading to a fall in blood pressure, which gets gradually normalised ([@B29]; [@B82]).

Safety Profile of *C. prostratus* {#s6_10}
---------------------------------

The ethanolic and aqueous extracts of the CP leaves have been evaluated for acute oral toxicity study in albino Wistar rats. The animals did not show any toxicity or behavioural changes up to the dose of 5,000 mg/Kg ([@B3]). Similarly, the iron oxide nanoparticles of the CP herb exhibited maximum tolerable dose up to 2,000 mg/Kg in Swiss albino mice with no clinical signs of toxicity. The histopathology of brain also did not show any aberrations or degeneration of neurons. Furthermore, no inflammation was observed in the heart and liver ([@B75]). These toxicological studies, therefore, confirmed that the administration of CP is safe for the vital organs within the respective treatment durations.

Summary and Way Forward {#s6_11}
-----------------------

The use of herbal medicines continues to escalate rapidly with about 70% of the world population still relying upon traditional medicines for their primary healthcare needs. The natural plant products have negligible toxicities, if any, and are endowed with a multitude of phytoconstituents which are responsible for their holistic therapeutic action. Cognitive dysfunction is one of the major health problem in today\'s world, wherein the available synthetic chemotherapeutic modalities have proven to be non-absolute and, at times toxic in nature. In such a scenario, safer herbal alternative medicines play a vital role in managing the neurological etiologies. One such cognitive booster herb is *C. prostratus* Forssk., commonly known as *Shankhpushpi*, which is mainly endowed with neuroprotective, nootropic and neuro-modulatory activities ([**Figure 1B**](#f1){ref-type="fig"}). Besides, it also possesses several other therapeutic properties, such as immunomodulatory, antimicrobial, antidiabetic and cardioprotective activities. The fundamental bioactive compounds responsible for the nootropic activities of this herb have been identified as 4\'-methoxy kaempferol, 7-methoxy quercetin, convolamine, scopoletin, ceryl alcohol, β-sitosterol and hydroxy-cinnamic acid. Additionally, this herb did not exhibit any signs of toxicity and neurodegeneration up to a dose of 2000 mg/Kg in mice, thereby indicating its safety profile. A few initial clinical trials have conducted for CP, however, more detailed and controlled clinical trials are needed to establish and validate the neuro-pharmacological profile of *C. prostratus*. In addition, detailed mechanistic studies are yet to be executed to unravel the underlying mechanism of action for this cognition enhancing herb. Taken together, *C. prostratus* is likely to be the front runner for the clinical phyto-pharmaceutical status for treatment of neurological ailments.
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